Vulvar dermatology is one of those areas where small misses can really add up. Symptoms can affect quality of life, and in some cases, result in scarring and permanent architecture changes. Dr Murphy—assistant professor of Dermatology and director of the Vulvar Health Program at George Washington University—walked through six key lessons she’s learned from caring for patients with vulvar diseases and offered practical diagnostic and management pearls. A reassuring takeaway is that many vulvar dermatoses respond well to treatment once the diagnosis is made. Here’s a summary of her session in case you missed it.
A Practical Clinic Approach (how I’m taking this back to my exam room)
Think in buckets, not in one diagnosis.
When symptoms include itch, burn, or pain, I’m now mentally sorting into:
-
- Inflammatory dermatoses (lichen sclerosus, lichen planus, psoriasis, lichen simplex chronicus)
- Irritant/allergic contact dermatitis (wipes, pads, detergents, fragrances)
- Low-estrogen atrophic vaginitis / GSM (dryness, burning, dyspareunia)
- Infection/overgrowth (don’t ignore, but don’t anchor here)
- Neoplasia/premalignancy when morphology or clinical course doesn’t fit (know when to biopsy)
High-Yield Case-Based Clinical Pearls I’m keeping
-
- Lichen sclerosus (LS): treat it as a chronic inflammatory disease, not a one-and-done rash.
Case: 65 yoF with a history of prurigo nodularis on nemolizumab presented for itchy and painful tears to the vulvar skin. Physical examination revealed “crinkly” skin on the clitoral hood and posterior fourchette. This crinkly skin is the texture change or hyperkeratosis of LS, which is a tell-tell sign of disease activity.
-
- High-potency topical steroid is first-line in improving symptoms and clinical signs.
- After induction (for 12 weeks), maintenance therapy is needed. Dr Murphy recommends switching to 2-3 times per week.
- It is important to know areas of involvement. Characteristic sites of involvement for LS include the clitoris and clitoral hood, interlabial sulci, labia minora and perineum.
- The vast majority of patients respond to topical steroids. For resistant cases, other therapies to consider include hydroxychloroquine, methotrexate, acitretin, as well as JAK inhibitors and biologics.
- Lastly, there is a risk of squamous cell carcinoma (SCC), which the precursor being differentiated vulvar intraepithelial neoplasia (VIN). Consider this for nonhealing ulcers or nodules, which warrants a biopsy.
-
- Don’t forget that infections can happen
-
- Candida albicans classically presents with thick, white discharge, however, an important reminder is that candida albicans doesn’t always present with any discharge. Sometimes, you can also see erythema, scaling, or even pustules, which can make the diagnosis less obvious. Common risk factors for candida infection includes clobetasol, diabetes medications, IL-17 inhibitors and hormone therapy.
- Although commonly present on the proximal media thigh, interestingly, tinea can also affect the labia. In this circumstance, oral terbinafine is the treatment of choice given its presence on a hair bearing site.
- HSV classically presents with grouped erosions, however, it can present as a single small erosion. If you see an erosion, presume it is HSV, perform a PCR and start valacyclovir while you await the results.
-
- Always spread the labia
Case: Dr Murphy notes a case of a patient with hidradenitis suppurativa (HS) with pruritus thought to be secondary to her HS. However, when the labia majora were separated to examine the inner vulva, there were extensive lichenification of her inner labia majora and minor with geometric erosions, consistent with lichen simplex chronicus (LSC).
LSC is the result of chronic scratching or rubbing. The goal with treatment is to eliminate triggers and break the itch-scratch cycle. Topical steroids are the mainstay of therapy. In the event that the itch-scratch cycle persists, consider switching to non-steroidal creams or IL-13 versus IL-31 inhibitors depending on the severity.
-
- Erosive Lichen planus and lichen sclerosus can coexist
Case: 45yoF with biopsy proven lichen sclerosus presented with 2-month history of a vulvar rash that led to closing of her vaginal opening. On physical examination, only a single finger could be inserted about 2 cm. While the patient presented with a biopsy showing LS, remember, lichen sclerosus does not affect the vagina so this patient was diagnosed with vaginal erosive lichen planus and vulvar lichen sclerosus. LS and LP can overlap in distinct areas as in this patient or can overlap within the vulva. Treatment of erosive lichen planus is challenging. Initial topical therapy can include triamcinolone cream as it tends to absorb better through the mucosa and hydrocortisone suppository, but escalation to systemic therapy is often needed. A dilator is also recommended to prevent scarring of the Importantly, long-standing erosive disease should be monitored as there is an association with SCC. Therefore, persistent or atypical areas should be biopsied when warranted.
-
- Low estrogen / GSM is a dermatology problem too.
Case: 45yoF presented with dyspareunia and several year history of OCP use. On physical examination, there was a red papule at the urethral opening, consistent with a urethral caruncle, which is a classic sign for atrophic vaginitis. When related to menopause, atrophic vaginal is also called genitourinary syndrome of menopause, but this can also occur with other hormone-altering states including OCP use, breastfeeding, or surgical/chemical induced menopause. Patients may describe burning, rawness, recurrent irritation, and dyspareunia. Initial therapy includes topical estradiol which is safe and effective for atrophic vaginitis.
-
- Don’t forget about contact dermatitis.
Contact dermatitis can trigger LSC. “Gentle” products aren’t always gentle. Wipes, pantyliners, and scented washes can perpetuate or exacerbate the itch-scratch cycle. In these situations, part of management is identifying, removing and counseling patients on triggers while also treating the underlying inflammation with topical steroids.
Takeaway
Treating vulvar dermatoses requires the right diagnosis, right treatment, and building trust with the patient. When we take the time to normalize what they’re experiencing, do a careful exam, and be thoughtful about treatment, it can make a big difference. Many patients not only start to feel better physically, but they also feel heard.
Did you enjoy this article? You can find more on Medical Dermatology here.



